Stay updated on Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision: v3.6.4 has been added to the page, replacing the previous v3.6.3. This reflects a new build/version of the page template and does not change the study content.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.6.3 is now displayed, replacing the previous v3.6.2. This indicates a page version update without altering the study content visible to users.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2. This denotes a small CMS/page update rather than a substantive change to the study details or content.SummaryDifference0.0%

- Check55 days agoChange DetectedNew sections How to Read a Study Record, Common Questions, and How to Join a Study have been added, and a note indicates no participants are currently being recruited. The Intervention/Treatment header formatting was adjusted and the revision label updated to v3.6.0.SummaryDifference0.4%

- Check62 days agoChange DetectedThe page’s revision history now displays Revision: v3.5.5, replacing the previous Revision: v3.5.4. This updates the revision record without altering the study details.SummaryDifference0.0%

- Check84 days agoChange DetectedThe page's revision/version label was updated from v3.5.3 to v3.5.4, indicating a minor update to the page version.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page.